Target intelligence / Profile preview

Ribosomal protein L3 pseudogene 11 (RPL3P11)

Target
RPL3P11
Molecular classification
Other (pseudogene), processed pseudogene
01

Overview

Ribosomal protein L3 pseudogene 11 (RPL3P11) is a processed pseudogene in the human genome. It does not encode a functional protein and has no known biological activity. RPL3P11 is one of many pseudogenes related to the ribosomal protein L3 gene (RPL3), which encodes a structural component of the 60S subunit of the ribosome[2][4][5]. Like other ribosomal protein pseudogenes, RPL3P11 is considered non-functional and is not recognized as a therapeutic drug target or implicated in disease, mechanism of action, patient biomarker use, or safety concerns. This entry is likely not relevant for drug discovery or therapeutic targeting due to its status as a pseudogene. Notes: - RPL3P11 is frequently listed in genetic databases as a processed pseudogene and not as a functional protein or therapeutic target[2][4]. - Most ribosomal protein pseudogenes, including RPL3P11, arise from duplication and subsequent mutation of the parental ribosomal protein gene and are not expressed or functional in protein synthesis[2][4][5]. - Information on the functional parent gene, RPL3, relates to roles in protein synthesis and ribosome structure, but this does not apply to its pseudogenes[1][3].

Other names
RPL3_7_963RPL3P11

Beyond the preview

Go deeper on Ribosomal protein L3 pseudogene 11 (RPL3P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L3 pseudogene 11 (RPL3P11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call